Вестник БГУ. Медицина и фармация
Библиографическое описание:
, , ПСИХОЭМОЦИОНАЛЬНЫЕ РАССТРОЙСТВА У ПАЦИЕНТОВ, ПЕРЕНЕСШИХ ИНСУЛЬТ, И ИХ СОВРЕМЕННАЯ ФАРМАКОТЕРАПИЯ // Вестник БГУ. Медицина и фармация. - 2024. №1. . - С. 3-12.
Заглавие:
ПСИХОЭМОЦИОНАЛЬНЫЕ РАССТРОЙСТВА У ПАЦИЕНТОВ, ПЕРЕНЕСШИХ ИНСУЛЬТ, И ИХ СОВРЕМЕННАЯ ФАРМАКОТЕРАПИЯ
Финансирование:
Работа выполнена в рамках инициативного гранта ФГБОУ ВО «Бурятский государ- ственный университет имени Доржи Банзарова».
Коды:
Аннотация:
Инсульт остается важной медико-социальной проблемой в мире, занимающей лидирующее место в первичной инвалидизации населения. Зачастую после инсульта у больного на передний план выходят возникший двигательный дефицит, бульбарные нарушения и снижение когнитивной функции определяющие степень независимости и инвалидизации пациента, тогда как изменение психоэмоционального состояния явно незаметно, хотя именно оно играет решающее значение в процессе реабилитации пациента [1]. Представлен обзор литературы российской электронной библиотеки eLIBRARY и библиотеки PubMed Национального центра биотехнологической информации (NCBI) США. В результате проведенного исследования, касающегося постинсультных психоэмоциональных нарушений, изложено ее современное представление, обозначены малоизученные аспекты и актуальные подходы к фармакотерапии.
Ключевые слова:
инсульт, острый период, реабилитация, психоэмоциональное состояние, психоэмоциональные расстройства, факторы риска, фармакотерапия, анти- депрессанты, будущие исследования.
Список литературы:
Emelin A. U., Lobzin V. U. Possibilities of combined use of peptides in the treatment of post-stroke asthenia // Neurology, Neuropsychiatry, Psychosomatics. 2023. Vol. 15. P. 117‒124.
Hackett M. L., Kohler S., O'Brien J. T., Mead G. E. Neuropsychiatric outcomes of stroke // Lancet Neurol. 2014. Vol. 13, No. 5. P. 525‒534.
Hinkle J. L., Becker K. J., Kim J. S. et al. Poststroke fatigue: Emerging evidence and approaches to management: A scientific statement for healthcare professionals from the Ameri- can Heart Association // Stroke. 2017. Vol. 48. P. 159‒170.
Van Dijk M. J., de Man-van Ginkel J. M., Hafsteinsdóttir T. B., Schuurmans M. J. Iden- tifying depression post-stroke in patients with aphasia: a systematic review of the reliability, va- lidity and feasibility of available instruments // Clin Rehabil. 2016. Vol. 30. P. 795‒810.
Hackett M. L., Pickles K. Part I: Frequency of depression after stroke: An updated sys- tematic review and meta-analysis of observational studies // Int J Stroke. 2014. Vol. 9. P. 1017‒ 25.
Towfighi A., Ovbiagele B., El Husseini N. et al. Poststroke depression: A scientific state- ment for healthcare professionals from the American Heart Association/American Stroke Asso- ciation // Stroke. 2017. Vol. 48. P. 30‒43.
Robinson R. G., Jorge R. E. Post-stroke depression: A review // Am J Psychiatry. 2016. Vol. 173. P. 221‒31.
Wei N., Yong W., Li X. et al. Post-stroke depression and lesion location: A systematic review // J Neurol. 2015. Vol. 262. P. 81‒90.
Gainotti G., Marra C. Determinants and consequences of post-stroke depression // Cur- rent Opinion in Neurology. 2002. Vol. 15. P. 85‒89.
Sanchez C., Reines E. H., Montgomery S. A. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike? // Int Clin Psychopharmacol. 2014. Vol. 29. P. 185‒ 196.
Mandrioli R., Protti M., Mercolini L. New-generation, non-SSRI antidepressants: Ther- apeutic drug monitoring and pharmacological interactions. Part 1: SNRIS, SMSS, SARIS // Cur- rent Medicinal Chemistry. 2018 Vol. 25. P. 772‒792.
Miller E. L., Murray L., Richards L. et al. Comprehensive overview of nursing and inter- disciplinary rehabilitation care of the stroke patient: A scientific statement from the American Heart Association // Stroke. 2010. Vol. 41. P. 2402‒2448.
Sagen U., Vik T. G., Moum T., Morland T., Finset A., Dammen T. Screening for anxiety and depression after stroke: Comparison of the Hospital Anxiety and Depression Scale and the Montgomery and Asberg Depression Rating Scale // J Psychosom Res. 2009. Vol. 67. P. 325‒ 332
Lincoln N. B., Brinkmann N., Cunningham S., et al. Anxiety and depression after stroke: A 5 year follow-up // Disability and Rehabilitation. 2013. Vol. 35. P. 140‒145.
Knapp P., Campbell Burton C. A., Holmes J. et al. Interventions for treating anxiety after stroke // Cochrane Database of Systematic Reviews. 2017. No. 5. P. 154‒162.
Kim J. S., Bashford G., Murphy T. K. et al. Safety and efficacy of pregabalin in patients with central post-stroke pain // Pain. 2011. Vol. 152. No. 5. P. 1018‒1023.
Kim J. S., Choi-Kwon S. Disturbances in the voluntary control of emotional expression after stroke. // In: Ferro J. M., editor. Neuropsychiatric Symptoms of Cerebrovascular Diseases. Springer, 2013. P. 131‒160.
Kim J. S., Choi-Kwon S. Poststroke depression and emotional incontinence: Correlation with lesion location // Neurology. 2000. Vol. 54, No. 9. P. 1805‒1810.
Choi-Kwon S., Han S.W., Kwon S.U. et al. Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: A double-blind, placebo-controlled study // Stroke. 2006. Vol. 37. P. 156‒161.
Peeters M., Romieu P., Maurice T. et al. Involvement of the sigma 1 receptor in the mod- ulation of dopaminergic transmission by amantadine // European Journal of Neuroscience. 2004. Vol. 19. P. 2212‒2220.
Patatanian E., Casselman J. Dextromethorphan/quinidine for the treatment of pseudo- bulbar affect // The Consultant Pharmacist: the journal of the American Society of Consultant Pharmacists. 2014. Vol. 29. P. 264‒269.
Choi-Kwon S., Han K., Cho K. H. et al. Factors associated with post-stroke anger prone- ness in ischaemic stroke patients // European Journal of Neurology. 2013. Vol. 20. P. 1305‒1310.
Rosa P. B., Orquiza B., Rocha F. B. et al. Anger and stroke: A potential association that deserves serious consideration // Acta Neuropsychiatrica. 2016. Vol. 28. P. 346‒351.
Kim J. S., Lee E. J., Chang D. I. et al. Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: A multicentre, double-blind, randomised, placebo-controlled study // The Lancet Psychiatry. 2017. Vol. 4. P. 33‒41.
Fleminger S., Greenwood R. J., Oliver D. L. Pharmacological management for agitation and aggression in people with acquired brain injury // Cochrane Database of Systematic Reviews. 2006. P. 24‒32.
Drummond A., Hawkins L., Sprigg N. et al. The Nottingham Fatigue after Stroke (Not- FAST) study: Factors associated with severity of fatigue in stroke patients without depression // Clinical Rehabilitation. 2017. P. 1–10.
Kim J. S. Post-stroke mood and emotional disturbances: Pharmacological therapy based on mechanisms // Journal of Stroke. 2016. Vol. 18. P. 244‒255.
Choi-Kwon S., Ko M., Jun S.E. et al. Post-stroke fatigue may be associated with the promoter region of a monoamine oxidase A gene polymorphism // Cerebrovascular Diseases. 2017. Vol. 43. P. 54‒58.
Karaiskos D., Tzavellas E., Spengos K. et al. Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue // The Journal of Neuropsychiatry and Clinical Neurosciences. 2012. Vol. 24. P. 349‒353.
Bivard A., Lillicrap T., Krishnamurthy V. et al. MIDAS (modafinil in debilitating fatigue after stroke): A randomized, double-blind, placebo-controlled, crossover trial // Stroke. 2017. Vol. 48. P. 1293‒1298.
Hackett M. L., Kohler S., O'Brien J. T., Mead G. E. Neuropsychiatric outcomes of stroke // Lancet Neurol. 2014. Vol. 13, No. 5. P. 525‒534.
Hinkle J. L., Becker K. J., Kim J. S. et al. Poststroke fatigue: Emerging evidence and approaches to management: A scientific statement for healthcare professionals from the Ameri- can Heart Association // Stroke. 2017. Vol. 48. P. 159‒170.
Van Dijk M. J., de Man-van Ginkel J. M., Hafsteinsdóttir T. B., Schuurmans M. J. Iden- tifying depression post-stroke in patients with aphasia: a systematic review of the reliability, va- lidity and feasibility of available instruments // Clin Rehabil. 2016. Vol. 30. P. 795‒810.
Hackett M. L., Pickles K. Part I: Frequency of depression after stroke: An updated sys- tematic review and meta-analysis of observational studies // Int J Stroke. 2014. Vol. 9. P. 1017‒ 25.
Towfighi A., Ovbiagele B., El Husseini N. et al. Poststroke depression: A scientific state- ment for healthcare professionals from the American Heart Association/American Stroke Asso- ciation // Stroke. 2017. Vol. 48. P. 30‒43.
Robinson R. G., Jorge R. E. Post-stroke depression: A review // Am J Psychiatry. 2016. Vol. 173. P. 221‒31.
Wei N., Yong W., Li X. et al. Post-stroke depression and lesion location: A systematic review // J Neurol. 2015. Vol. 262. P. 81‒90.
Gainotti G., Marra C. Determinants and consequences of post-stroke depression // Cur- rent Opinion in Neurology. 2002. Vol. 15. P. 85‒89.
Sanchez C., Reines E. H., Montgomery S. A. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike? // Int Clin Psychopharmacol. 2014. Vol. 29. P. 185‒ 196.
Mandrioli R., Protti M., Mercolini L. New-generation, non-SSRI antidepressants: Ther- apeutic drug monitoring and pharmacological interactions. Part 1: SNRIS, SMSS, SARIS // Cur- rent Medicinal Chemistry. 2018 Vol. 25. P. 772‒792.
Miller E. L., Murray L., Richards L. et al. Comprehensive overview of nursing and inter- disciplinary rehabilitation care of the stroke patient: A scientific statement from the American Heart Association // Stroke. 2010. Vol. 41. P. 2402‒2448.
Sagen U., Vik T. G., Moum T., Morland T., Finset A., Dammen T. Screening for anxiety and depression after stroke: Comparison of the Hospital Anxiety and Depression Scale and the Montgomery and Asberg Depression Rating Scale // J Psychosom Res. 2009. Vol. 67. P. 325‒ 332
Lincoln N. B., Brinkmann N., Cunningham S., et al. Anxiety and depression after stroke: A 5 year follow-up // Disability and Rehabilitation. 2013. Vol. 35. P. 140‒145.
Knapp P., Campbell Burton C. A., Holmes J. et al. Interventions for treating anxiety after stroke // Cochrane Database of Systematic Reviews. 2017. No. 5. P. 154‒162.
Kim J. S., Bashford G., Murphy T. K. et al. Safety and efficacy of pregabalin in patients with central post-stroke pain // Pain. 2011. Vol. 152. No. 5. P. 1018‒1023.
Kim J. S., Choi-Kwon S. Disturbances in the voluntary control of emotional expression after stroke. // In: Ferro J. M., editor. Neuropsychiatric Symptoms of Cerebrovascular Diseases. Springer, 2013. P. 131‒160.
Kim J. S., Choi-Kwon S. Poststroke depression and emotional incontinence: Correlation with lesion location // Neurology. 2000. Vol. 54, No. 9. P. 1805‒1810.
Choi-Kwon S., Han S.W., Kwon S.U. et al. Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: A double-blind, placebo-controlled study // Stroke. 2006. Vol. 37. P. 156‒161.
Peeters M., Romieu P., Maurice T. et al. Involvement of the sigma 1 receptor in the mod- ulation of dopaminergic transmission by amantadine // European Journal of Neuroscience. 2004. Vol. 19. P. 2212‒2220.
Patatanian E., Casselman J. Dextromethorphan/quinidine for the treatment of pseudo- bulbar affect // The Consultant Pharmacist: the journal of the American Society of Consultant Pharmacists. 2014. Vol. 29. P. 264‒269.
Choi-Kwon S., Han K., Cho K. H. et al. Factors associated with post-stroke anger prone- ness in ischaemic stroke patients // European Journal of Neurology. 2013. Vol. 20. P. 1305‒1310.
Rosa P. B., Orquiza B., Rocha F. B. et al. Anger and stroke: A potential association that deserves serious consideration // Acta Neuropsychiatrica. 2016. Vol. 28. P. 346‒351.
Kim J. S., Lee E. J., Chang D. I. et al. Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: A multicentre, double-blind, randomised, placebo-controlled study // The Lancet Psychiatry. 2017. Vol. 4. P. 33‒41.
Fleminger S., Greenwood R. J., Oliver D. L. Pharmacological management for agitation and aggression in people with acquired brain injury // Cochrane Database of Systematic Reviews. 2006. P. 24‒32.
Drummond A., Hawkins L., Sprigg N. et al. The Nottingham Fatigue after Stroke (Not- FAST) study: Factors associated with severity of fatigue in stroke patients without depression // Clinical Rehabilitation. 2017. P. 1–10.
Kim J. S. Post-stroke mood and emotional disturbances: Pharmacological therapy based on mechanisms // Journal of Stroke. 2016. Vol. 18. P. 244‒255.
Choi-Kwon S., Ko M., Jun S.E. et al. Post-stroke fatigue may be associated with the promoter region of a monoamine oxidase A gene polymorphism // Cerebrovascular Diseases. 2017. Vol. 43. P. 54‒58.
Karaiskos D., Tzavellas E., Spengos K. et al. Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue // The Journal of Neuropsychiatry and Clinical Neurosciences. 2012. Vol. 24. P. 349‒353.
Bivard A., Lillicrap T., Krishnamurthy V. et al. MIDAS (modafinil in debilitating fatigue after stroke): A randomized, double-blind, placebo-controlled, crossover trial // Stroke. 2017. Vol. 48. P. 1293‒1298.
Статья.pdf